Fetal Bovine Serum Market Size To Reach $6.91 Billion By 2033

November 2025 | Report Format: Electronic (PDF)

Fetal Bovine Serum Market Growth & Trends

The global fetal bovine serum market size is expected to reach USD 6.91 billion by 2033, registering a CAGR of 14.44% from 2025 to 2033, according to a new report by Grand View Research, Inc. One of the key market-driving factors includes the remarkable growth of the applications of cell & tissue culture in diagnostics, research, pharmaceutical, and biotech industries.

Factors contributing to the growth of the fetal bovine serum (FBS) market include the increasing use of cell-based assays in drug discovery and development, the rising demand for biologics and biosimilars, and the growing investment in regenerative medicine and stem cell research. However, there are concerns about the ethical and environmental implications of using FBS, and alternative serum-free media and supplements are being developed to meet these concerns.

The market is offering manufacturers lucrative growth prospects due to technological development and company portfolio expansion in the serum space. Fetal bovine serum is in exceptionally high demand as a result of the pace at which R&D operations are developing technology. Fetal bovine serum has a wide range of uses, which motivates the biopharmaceutical industry to create therapies and medications that use animals as their primary ingredient. The use of animal hosts for the production of drugs and vaccines has a number of benefits, including low-cost and high-volume production of the final product. This element is expected to fuel market expansion in the years to come.

Furthermore, the pandemic has positively impacted the FBS market. It has led to a surge in demand for vaccines and therapeutics, which has increased the demand for FBS as an important component in cell culture media. This has led to further strain on the already limited supply of FBS. To address this shortage, companies are exploring alternative sources of animal serum and developing serum-free media for cell culture. Moreover, ethical concerns regarding the use of animal-derived products, including FBS, have increased during the pandemic. This has led to a growing demand for plant-based or synthetic alternatives to FBS. The development of such alternatives is still in the early stages, but it is likely to gain momentum in the coming years.

key Request a free sample copy or view report summary: Fetal Bovine Serum Market Report

Fetal Bovine Serum Market Report Highlights

The cell-based research segment dominated the market in 2024, accounting for 28.73%. The rise in cell culture techniques in drug discovery, cancer research, stem cell research, and regenerative medicine, along with increased investments in biologics and cell therapy development, is expected to drive growth in this segment.
The pharmaceutical and biotechnology companies segment held the highest market share of 33.33% in 2024 due to the increasing adoption of fetal bovine serum in drug development.
North America dominated the global fetal bovine serum (FBS) market in 2024, with a share of 37.60%, owing to the region’s well-established biotechnology and biopharmaceutical industries.
The fetal bovine serum market in the Asia-Pacific region is expected to grow at the fastest CAGR of 15.92% over the forecast period, driven by increasing investments in biotechnology and pharmaceutical R&D.